These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 16479070)
21. Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma. Zhang C; Wang YE; Zhang P; Liu F; Sung CJ; Steinhoff MM; Quddus MR; Lawrence WD Hum Pathol; 2010 Feb; 41(2):255-61. PubMed ID: 19896693 [TBL] [Abstract][Full Text] [Related]
22. Determination of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in borderline and low-grade ovarian cancers. Sadlecki P; Walentowicz P; Bodnar M; Marszalek A; Grabiec M; Walentowicz-Sadlecka M Tumour Biol; 2017 May; 39(5):1010428317706230. PubMed ID: 28488545 [TBL] [Abstract][Full Text] [Related]
23. Stage-specific embryonic antigen 4 expression in epithelial ovarian carcinoma. Ye F; Li Y; Hu Y; Zhou C; Hu Y; Chen H Int J Gynecol Cancer; 2010 Aug; 20(6):958-64. PubMed ID: 20683402 [TBL] [Abstract][Full Text] [Related]
24. [Lymphatic metastasis and VEGF-C expression in ovarian epithelial tumors]. Ding MX; Li JC; Tang XH Shi Yan Sheng Wu Xue Bao; 2003 Dec; 36(6):445-52. PubMed ID: 14724935 [TBL] [Abstract][Full Text] [Related]
25. [Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma]. Sun LX; Wu Y; Han HQ; Wang QH Ai Zheng; 2003 Jan; 22(1):58-61. PubMed ID: 12561438 [TBL] [Abstract][Full Text] [Related]
26. [Expression of topoisomerase III alpha in epithelial ovarian tumors of different types and relation between the expression of topoisomerase III alpha and the clinical pathology of tumor]. Zhang WY; Pan Y; Zhu LR; Zhang JZ; Zhang M; Feng K; Zhou L; Yu L; Zhang XM; Ng SW Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2988-91. PubMed ID: 16324386 [TBL] [Abstract][Full Text] [Related]
27. Expression of extracellular matrix proteins in ovarian serous tumors. Salani R; Neuberger I; Kurman RJ; Bristow RE; Chang HW; Wang TL; Shih IeM Int J Gynecol Pathol; 2007 Apr; 26(2):141-6. PubMed ID: 17413980 [TBL] [Abstract][Full Text] [Related]
28. Primary ovarian mucinous tumors with signet ring cells: report of 3 cases with discussion of so-called primary Krukenberg tumor. McCluggage WG; Young RH Am J Surg Pathol; 2008 Sep; 32(9):1373-9. PubMed ID: 18670351 [TBL] [Abstract][Full Text] [Related]
29. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms. O'Neill CJ; Deavers MT; Malpica A; Foster H; McCluggage WG Am J Surg Pathol; 2005 Aug; 29(8):1034-41. PubMed ID: 16006797 [TBL] [Abstract][Full Text] [Related]
30. Immunohistochemistry with apoptotic-antiapoptotic proteins (p53, p21, bax, bcl-2), c-kit, telomerase, and metallothionein as a diagnostic aid in benign, borderline, and malignant serous and mucinous ovarian tumors. Ozer H; Yenicesu G; Arici S; Cetin M; Tuncer E; Cetin A Diagn Pathol; 2012 Sep; 7():124. PubMed ID: 22995373 [TBL] [Abstract][Full Text] [Related]
31. Calcifications in mucinous and serous cystic ovarian tumors. Okada S; Ohaki Y; Inoue K; Kawamura T; Hayashi T; Kato T; Kumazaki T J Nippon Med Sch; 2005 Feb; 72(1):29-33. PubMed ID: 15834205 [TBL] [Abstract][Full Text] [Related]
32. Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT. Rushing RS; Shajahan S; Chendil D; Wilder JL; Pulliam J; Lee EY; Ueland FR; van Nagell JR; Ahmed MM; Lele SM Gynecol Oncol; 2003 Oct; 91(1):9-14. PubMed ID: 14529657 [TBL] [Abstract][Full Text] [Related]
33. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours. Evans MF; McDicken IW; Herrington CS J Pathol; 1999 Sep; 189(1):53-9. PubMed ID: 10451488 [TBL] [Abstract][Full Text] [Related]
34. Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2. Brun JL; Cortez A; Commo F; Uzan S; Rouzier R; Daraï E Int J Oncol; 2008 Dec; 33(6):1239-46. PubMed ID: 19020757 [TBL] [Abstract][Full Text] [Related]
35. Inhibitory role of prohibitin in human ovarian epithelial cancer. Jia L; Ren JM; Wang YY; Zheng Y; Zhang H; Zhang Q; Kong BH; Zheng WX Int J Clin Exp Pathol; 2014; 7(5):2247-55. PubMed ID: 24966933 [TBL] [Abstract][Full Text] [Related]
36. [Association of EGFR expression with angiogenesis and chemoresistance in ovarian carcinoma]. Chen AP; Zhang J; Liu H; Zhao SP; Dai SZ; Sun XL Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):48-52. PubMed ID: 19538870 [TBL] [Abstract][Full Text] [Related]
37. [Expression and significance of P53, P21WAF1 and CDK1 proteins in epithelial ovarian cancer]. Shi HR; Zhang RT Ai Zheng; 2009 Aug; 28(8):882-5. PubMed ID: 19664338 [TBL] [Abstract][Full Text] [Related]
38. Simultaneous mucinous cystadenoma of ovary and mucinous cystadenocarcinoma of pancreas. Gagne LJ; Colacchio T; Longnecker DS Int J Pancreatol; 2000 Aug; 28(1):9-13. PubMed ID: 11185714 [TBL] [Abstract][Full Text] [Related]
39. Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary. Fujita M; Enomoto T; Inoue M; Tanizawa O; Ozaki M; Rice JM; Nomura T Jpn J Cancer Res; 1994 Dec; 85(12):1247-56. PubMed ID: 7852189 [TBL] [Abstract][Full Text] [Related]
40. K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary. Enomoto T; Weghorst CM; Inoue M; Tanizawa O; Rice JM Am J Pathol; 1991 Oct; 139(4):777-85. PubMed ID: 1656759 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]